Literature DB >> 2854135

High-performance liquid chromatographic procedure for the determination of a new anti-gastric ulcer agent, 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propioni c acid, in human plasma and urine.

Y Shioya1, T Shimizu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2854135     DOI： 10.1016/0378-4347(88)80089-6

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  4 in total

1.  Local gastric and serum concentrations of rebamipide following oral ingestion in healthy volunteers.

Authors:  Taiji Akamatsu; Naoshi Nakamura; Naoyuki Furuya; Toshiki Shimizu; Akira Gotou; Kendo Kiyosawa; Tsutomu Katsuyama; Takahiko Osumi; Yukihiro Hirao; Gohatiro Miyamoto
Journal:  Dig Dis Sci       Date:  2002-06       Impact factor: 3.199

2.  Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects.

Authors:  Taiji Akamatsu; Tadanobu Nagaya; Shinya Ichikawa; Takamori Sudo; Ryutaro Takeda; Kazuhiro Takenaka; Ryo Kodama; Tetsuya Ito; Norikazu Arakura; Eiji Tanaka
Journal:  J Clin Biochem Nutr       Date:  2010-10-29       Impact factor: 3.114

3.  Optimization of forced degradation using experimental design and development of a stability-indicating liquid chromatographic assay method for rebamipide in bulk and tablet dosage form.

Authors:  Sandeep Sonawane; Paraag Gide
Journal:  Sci Pharm       Date:  2011-01-10

4.  A simple high performance liquid chromatography method for determination of rebamipide in rat urine.

Authors:  Dustin L Cooper; Sam Harirforoosh
Journal:  MethodsX       Date:  2014-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.